FundedIQ
Biotechnology

Qualigen: Funding, Investors & Team (Sep 2026)

Qualigen is a biotechnology company that is concentrating on creating and selling new therapeutic products for cancer and infectious diseases, as well as growing its popular FastPack® diagnostic platform.

www.qualigeninc.com LinkedIn Carlsbad, United States 11-50 employees
Total raised
$12.5M
Rounds
3
Latest
Undisclosed round
Jul 2025

Qualigen has raised $12.5M across 3 funding rounds on record, the most recent an undisclosed round of $4.5M announced in Jul 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Qualigen Company Profile and Key Stats

Total funding raised
$12.5M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$4.5M in Jul 2025
Employees
11-50
reported band
Headquarters
Carlsbad, United States

Latest funding round on record: Jul 2025.

Qualigen Funding Rounds

Date
Round
Amount
Undisclosed round
$4.5M
Undisclosed round
$4.5M
Undisclosed round
$3.5M

Qualigen raised $3.5M in an undisclosed round announced in Sep 2024.

2 months later, an undisclosed round of $4.5M was announced in Nov 2024.

8 months later, an undisclosed round of $4.5M was announced in Jul 2025.

Qualigen Founders and Leadership Team

Name
Role
Contact
Michael S Poirier
Founder
Locked

Contact details for the Qualigen team: 1 of 1 has an email address on file.

Start 14-day free trial →

Qualigen Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Qualigen's latest round of $4.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Qualigen in Biotechnology and Carlsbad

Companies Similar to Qualigen

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Qualigen Funding FAQs

What does Qualigen do?

Qualigen is a biotechnology company that is concentrating on creating and selling new therapeutic products for cancer and infectious diseases, as well as growing its popular FastPack® diagnostic platform.

How much funding has Qualigen raised?

Qualigen has raised $12.5M across 3 rounds on record. The most recent is an undisclosed round of $4.5M announced in Jul 2025.

When did Qualigen last raise funding?

Qualigen's most recent funding round on record is an undisclosed round of $4.5M, announced in Jul 2025.

Who founded Qualigen?

FundedIQ lists Michael S Poirier (Founder) at Qualigen.

Where is Qualigen headquartered?

Qualigen is based in Carlsbad, California, United States.

How many employees does Qualigen have?

Qualigen is in the 11-50 employee band.

How does Qualigen's funding compare to other Biotechnology startups?

Qualigen's latest round of $4.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Qualigen Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Qualigen is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.